CAIRO3_2D | R Documentation |
Kaplan-Meier digitized data from CAIRO3, figure 2D (PMID 25862517). A reported sample size of 558 for a primary endpoint of PFS2 in colorectal cancer.
CAIRO3_2D
A data frame of 557 observations and 3 variables:
time | event time (in months) | |
event | OS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (maintenance, observation) | |
Simkens LHJ, van Tinteren H, May A, et al. Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group. Lancet 2015; 385: 1843–52.
summary(CAIRO3_2D)
kmplot(CAIRO3_2D)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.